NCT04126083View on ClinicalTrials.gov

Lofexidine for Adults Undergoing Lumbar Spine Surgery

PHASE4CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

April 15, 2021

Study Completion Date

April 15, 2021

Conditions

Opioid Withdrawal

Interventions

DRUG

Lofexidine Oral Tablet

lofexidine 0.54 mg 4 times daily

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

USWM, LLC (dba US WorldMeds)

INDUSTRY

lead

Mayo Clinic

OTHER

NCT04126083 - Lofexidine for Adults Undergoing Lumbar Spine Surgery | Biotech Hunter | Biotech Hunter